July 2026 Random Ramblings

Episode Summary

Executive Summary: Andrew Walker’s July 2026 rambling focuses on the psychology of active investing: the arrogance required to seek alpha, when to admit a process or thesis is wrong, how to think about portfolio evolution without chasing momentum, and whether selling too early leaves money on the table. He also reflects on benchmarking against a market dominated by AI names and closes with frustration about London’s depressed public market, where many winners are being taken out at large premiums.

Main Topics: The arrogance and confidence required to be an active investor (Priority: 5/5): Walker argues that buying stocks is inherently an act of confidence/arrogance because it implies the investor believes they can outperform the market and beat base rates. He frames active investing as a zero-sum game where generating alpha requires being right when others are wrong. Knowing when to admit you’re wrong (Priority: 5/5): He wrestles with the question of when a bad investment is just noise versus evidence that the thesis or process is broken. He suggests a rough three-year rule for reassessing whether poor performance reflects the investor rather than the market. Evolving as an investor without becoming a momentum chaser (Priority: 5/5): Walker discusses how investors should adapt their process over time while staying true to core principles. He uses his own missed AI exposure and the debate around value investing versus growth/momentum as examples of this tension. Benchmarking, index weights, and the cost of being underexposed to AI (Priority: 4/5): He notes that large AI winners like NVIDIA are now such a large part of the S&P 500 that not owning them is effectively a short position versus the benchmark. This creates pressure on active managers who may be structurally underexposed to the market’s biggest drivers. Selling winners too early and hindsight on portfolio decisions (Priority: 5/5): Walker reviews past positions that performed much better after he sold, including biotech and AI-adjacent names. He questions whether he is turning the portfolio too fast, failing to let theses play out, or correctly recycling capital before the upside is exhausted. London’s depressed public market and takeover-driven value realization (Priority: 4/5): He closes with frustration about the London Stock Exchange, where many companies appear cheap but only realize value through takeover bids. He highlights a wave of large-premium acquisitions and wonders whether public-market investors are stuck waiting for private equity to unlock value.

Key Arguments: Active investing requires assuming you know something the market does not, which is inherently arrogant but necessary if you want alpha. If a stock or process has underperformed for years, investors should seriously ask whether the issue is their own judgment rather than market inefficiency. Value investors can get trapped by rigid principles; evolving the process may be necessary, but there is a fine line between evolution and chasing recent winners. Being out of major AI stocks is not a neutral position if those names are a large share of the benchmark; it can function like an implicit short. Selling winners too early may reflect impatience, but it can also be rational if the original value opportunity has already played out. In London, many stocks look cheap on public-market metrics, but the only meaningful path to value realization may be takeouts at large premiums. A portfolio can look bad relative to later outcomes even if the original trade was reasonable; the challenge is separating good process from bad luck and missed upside.

Data Points: Episode length: 23 minutes 6 seconds - Walker says the rambling was about 23:06 long, though he estimates it in the intro as roughly 23:30. Three-year rule: 3 years - He says that if an investment has gone nowhere for three years, it is time to look in the mirror and reassess whether the problem is the investor or the market. NVIDIA weight in S&P 500: 7.5% - He cites NVIDIA as representing 7.5% of the S&P 500, emphasizing benchmark concentration. London takeovers: 11 - He notes that Mighty was the 11th FTSE large-cap takeover of the year, signaling a wave of London public-company exits. Takeover premium universe: £1 billion+ takeovers - He refers to the 11th takeover of a company valued above £1 billion, suggesting large companies are being bought out at high premiums. Concentrated portfolio size: 10 stocks - He says that if an active manager runs a 10-stock portfolio, it is plausible they may have missed many of the big takeover winners in London. Nebius price move: 30 to 230 - He says Nebius rose from around 30 when he sold it to about 230 fifteen months later, illustrating a major missed winner. Nebius cost basis: 18–19 - He says his purchase cost basis for Nebius was around 18 or 19 before selling in the high 20s. Cure trade: below net cash to around 40 (peaked near 60) - He describes buying Cure below net cash and selling around cash, after the stock later surged on positive Hutchinson’s disease trial results. AI stock performance window: late 2025 to mid-2026 - He references missing AI trades after recognizing AI inflection late last year and seeing subsequent strong performance.

Pivotal Quotes: "Every time you buy a stock, every time you do research, you are saying, I think I am so smart." — Andrew Walker: He is explaining why active investing is fundamentally an arrogant act and why alpha-seeking requires confidence. "When do you need to say, it's not the market, it's me?" — Andrew Walker: This frames his central question about when investors should admit their process or thesis is failing. "The only way we'll ever get value is a private equity sale." — Andrew Walker: He uses this to capture the frustration of investing in London-listed companies that appear undervalued but may never rerate without a takeover.

Implications: Active investors should regularly stress-test both thesis and process, especially after multi-year underperformance or major benchmark shifts. In concentrated portfolios, missing a few huge winners can overwhelm otherwise solid process, making self-evaluation essential.